SCHEMBL7686785

SCHEMBL7686785

COC(=O)c1ccc(F)cc1N(S(C)(=O)=O)S(C)(=O)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.50
POLB P06746 1/20 0.45
MCOLN3 Q8TDD5 1/20 0.45
KCNH2 Q12809 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7691521 0.87 KMT2A (0.64) KMT2APOLBMCOLN3KCNH2SMN1; SMN2
SCHEMBL7555534 0.83 KMT2A (0.51) KMT2APOLBMCOLN3SMN1; SMN2KDM4E
SCHEMBL7550452 0.82 KMT2A (0.50) KMT2APOLBMCOLN3KCNH2SMN1; SMN2
SCHEMBL7555499 0.82 KMT2A (0.50) KMT2APOLBMCOLN3SMN1; SMN2KDM4E
SCHEMBL7550401 0.81 CFTR (0.57) KMT2APOLBMCOLN3SMN1; SMN2KDM4E
SCHEMBL6646528 0.81 SLC6A4 (0.45) KMT2ASMN1; SMN2KDM4EHSD17B10PSEN1
SCHEMBL7550963 0.80 KMT2A (0.46) KMT2APOLBMCOLN3SMN1; SMN2KDM4E
SCHEMBL23877553 0.80 PSEN1 (0.42) KMT2APOLBMCOLN3KCNH2SMN1; SMN2
SCHEMBL14012584 0.77 CES2 (0.61) POLBSMN1; SMN2KDM4ESLC6A4SLC6A3
SCHEMBL523258 0.77 CES2 (0.61) POLBSMN1; SMN2KDM4ESLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides MUSIL TIBOR (GB) 2002-04-18 US disclosed
US-6323155-B1 EXCELLENT LEVEL OF HERBICIDAL ACTIVITY TOGETHER WITH CROP TOLERANCE RHONE-POULENC AGRICULTURE LIMITED (GB) 2001-11-27 US disclosed
EP-0674629-B1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE POULENC AGRICULTURE (GB) 1998-07-08 EP disclosed
EP-0674629-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1995-10-04 EP disclosed
WO-1994014782-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1994-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides CBR3, CBR1, GLRA3 KMT2A 3499/4885POLB 2653/4885MCOLN3 2548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.